Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Dec. 31, 2003 - Feb. 26, 2004
Company* (Country; Symbol) | Company* (Country; Symbol) | Product | Terms/Details (Date) |
| |||
Agencourt Bioscience Corp.* | Various companies | Agencourt signed deals for distribution of its SPRI nucleic acid-purification chemistry technology | Agencourt signed deals with GenWorks Pty. Ltd. (Australia and New Zealand), Bluestar Ltd. (India), Pharmatech Inc. (Korea), Biolaboratories Pte. Ltd. (Singapore) and Genetic Research Instrumentation Ltd. (UK and France) (1/21) |
| |||
Ambion Inc.* | Applied Biosystems Group (NYSE:ABI) | Ambion's siRNA products and Applied Biosystems' PCR reagents | The companies will co-market the products for performing and monitoring the gene-knockdown effects of RNA interference in mammalian systems (1/19) |
| |||
Bioxel Pharma Inc. (Canada; TSE:BIP) | Cell Therapeutics Inc. (CTIC) | Bioxel will sell cGMP paclitaxel to CTI | The deal is worth at least C$1.2M (US$895,000) to Bioxel (2/19) |
| |||
Corautus Genetics Inc.* | Qiagen NV (the Netherlands; QGENF) and Strathmann Biotech AG* (Germany) | VEGF-2 plasmid for anticipated Phase III trials and future commercial use | Strathmann and Qiagen will manufacture the product; terms were not disclosed (1/8) |
| |||
Epoch Biosciences Inc. (EBIO) | Celera Diagnostics (joint venture of Celera Genomics Group and Applied Biosystems Group) | Nonexclusive deal for incorporation of Epoch technology into Celera products for certain infectious diseases | The license allows Celera to sell TaqMan probes that use Epoch's minor-groove binder and quencher in certain products; Epoch gets license fees and royalties on any end sales (2/10) |
| |||
SpectruMedix LLC* | Transgenomic Inc. (TBIO) | Transgenomic will distribute SpectruMedix's Reveal Genetic Analysis systems in Europe | Transgenomic's European marketing and sales organization will market and service the systems; terms were not disclosed (1/21) |
| |||
Nanogen Inc. (NGEN) | Transgenomic Inc. (TBIO) | Transgenomic will distribute Nanogen's NanoChip Molecular Biology Workstation in certain Western European countries | Transgenomic's European marketing and sales organization will market and service the instrument; terms were not disclosed (1/15) |
| |||
| |||
Notes: | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, stock symbols listed are on the Nasdaq market. | |||
NYSE = New York Stock Exchange; TSE = Toronto Stock Exchange. |